Institutional Ownership
Maravai Lifesciences Hldgs I
CUSIP 56600D107COM CL AMRVIQ1 2026
13D / 13G Filings
43
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
28.6%
Max % of class reported
Institutional Holders
154
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
43 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | 12 West Capital Management LP | 13G/A | 6.2% | 8.92M | SEC |
| 2 | Feb 13, 2026 | Hudson View Holdings LLC | 13G/A | 7.2% | 10.49M | SEC |
| 3 | Nov 14, 2025 | Hudson View Holdings LLC | 13G/A | 8.3% | 12.08M | SEC |
| 4 | Oct 31, 2025 | The Vanguard Group | 13G/A | 4.9% | 7.13M | SEC |
| 5 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 5.9% | 8.58M | SEC |
| 6 | Jul 29, 2025 | The Vanguard Group | 13G/A | 6.5% | 9.38M | SEC |
| 7 | May 29, 2025 | Hudson View Holdings LLC | 13G | 6.5% | 9.43M | SEC |
| 8 | Jan 28, 2025 | 12 West Capital Management LP | 13G/A | 8.2% | 11.59M | SEC |
| 9 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | 0.7% | 1.03M | SEC |
| 10 | Nov 13, 2024 | Maravai Life Sciences Holdings 2, LLC | 13G/A | 8.0% | 20.15M | SEC |
33 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Maravai Lifesciences Hldgs I.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Gtcr LLC | 20.15M | $57.02M |
| 2 | Braidwell LP | 10.24M | $28.98M |
| 3 | Blackrock, Inc. | 9.35M | $26.45M |
| 4 | 12 West Capital Management LP | 7.26M | $20.55M |
| 5 | Mackenzie Financial Corp | 6.31M | $17.85M |
| 6 | Renaissance Technologies LLC | 4.26M | $12.07M |
| 7 | Tejara Capital Ltd | 3.50M | $9.89M |
| 8 | Monaco Asset Management Sam | 3.42M | $9.68M |
| 9 | Morgan Stanley | 3.32M | $9.39M |
| 10 | Point72 Asset Management, L.P. | 3.21M | $9.07M |